Cell Painting is a high-content imaging approach that enables systematic characterization of cellular responses to chemical perturbations through quantitative morphological profiling. Although this methodology has been widely applied in drug discovery and functional genomics, ovarian cancer models remain comparatively underrepresented in Cell Painting studies. In the present work, we established a Cell Painting workflow for OVCAR-3 ovarian cancer cells and applied it to the phenotypic profiling of 54 anticancer compounds representing diverse mechanisms of action. Cells were exposed to compounds under short- and prolonged-treatment conditions, followed by multiplex fluorescent staining, high-content imaging, feature extraction using CellProfiler, and computational analysis of the resulting morphological profiles. Profiles obtained at the two treatment durations were analyzed separately. For each compound, the treatment condition showing greater within-compound consistency in PCA space was additionally retained to construct a combined dataset. Morphological relationships were explored using Pearson correlation analysis, dimensionality reduction, and unsupervised clustering. Morphological profiles showed reproducible relationships among compounds. Compounds with related mechanisms showed greater morphological similarity than expected by chance, although substantial within-class heterogeneity remained. Statistically significant cluster enrichment was observed for microtubule-targeting agents and topoisomerase inhibitors, whereas other mechanism-related patterns were incomplete. Among the evaluated clustering approaches, Leiden and agglomerative clustering produced similar separation of the Combined dataset, with silhouette scores of 0.486 and 0.482, respectively. Cell Painting identified mechanism-associated but heterogeneous morphological responses in OVCAR-3 cells. The results support the use of this model for exploratory phenotypic profiling while highlighting the influence of exposure conditions and the limited ability of morphology alone to recover annotated molecular mechanisms.
Cell Painting screens usually profile compounds at a single fixed endpoint. Many drug responses, however, develop over days, and compounds whose phenotypes are weak or still forming at the chosen endpoint give unstable profiles that move between clusters in repeated experiments and blur the phenotypic map. We profiled 53 small molecules in HCT116 cells after 48 h and 8 days of exposure, each in two independent iterations, and represented every compound by the window in which its replicate profiles were more stable. The resulting stability-weighted Combined map separated phenotypic groups more clearly than either single window (silhouette score of the modal partition 0.360 versus 0.227 and 0.292). This gain exceeded random window assignment (p = 0.002), also under analysis parameters chosen without the Combined dataset (p = 0.001). The number of compounds with inconsistent cluster assignment between iterations decreased (6 versus 16 and 13 of 53), although less consistently across analysis settings. The approach distinguishes compounds whose phenotypes are captured reproducibly at 48 h, compounds captured more reproducibly at 8 days, and a convergent group for which both windows give similar profiles. It offers a practical way to add a prolonged exposure window to phenotypic screens and to prioritize compounds for follow-up.